Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (7419)	1/5/2000 2:13:00 PM
From: biofisher	Respond to of 9719

I have accumulated a few hundred thousand shares of CORX over time (including struggling to get 10000 at 3/4 yesterday - couldn't fill my order for 40000 at 76 cents)CORX management was smart to avoid the reverse split trap to remain listed on NASDQ (temporarily if COCN an example). Their recent deal with Organon appears to give them the bucks to survive without lethal dilution. While Dr. Tracy has not put CORX on his recommended list, the January issue of Neuroinvestment paints an encouraging picture of CORX future and may be responsible for today's price advance.